Accelerating innovation and commercialization

Inno-Comm.jpg

Ottawa Health Innovation Hub future programs:

Centre for Bio-innovation

  • 14,000 sq. ft. dedicated wet lab incubation spaces with access to common and shared research and clinical infrastructure for new start-up biotech and life science ventures

  • 20,000 sq. ft. leasable lab space for collaborative research initiatives and private sector companies

  • access to uOttawa Faculty of Medicine core facilities

  • collaborative research opportunities and clinical trials development

Digital Health Sandbox

  • a digital health sandbox to provide digital health and medical technology companies with proof-of-concept resources to test and validate solutions in hospital, clinic and healthcare settings

Smart Health Accelerator

  • smart health accelerator programing for start-up medtech and digital health companies including a 5G/6G innovation platform, and a woman’s entrepreneurial accelerator program

  • access to a network of experienced advisors, mentors, regulatory specialists

  • business development support from the Telfer School of Management

  • access to a global network of venture capital and angel investors

Networking & Training

  • networking, entrepreneurial and regulatory compliance training, workshops, and conferences

Acc_3.jpg

The Hub’s world-class facilities are set to nurture generations of health science trailblazers, validate their discoveries, and transform not only the region’s diverse healthcare ecosystem, but also Canada’s global leadership in smart health and precision medicine.

iStock-157697835.jpg

The new Hub and AMRC will enable us to unleash our research capacity, technology, and our brightest minds to develop real world improvements to healthcare which will transform patient experiences and outcomes.

By end of 2031


Incubate 25+ biotech companies


Accelerate 50 medtech and digital health companies 


Attract $300M + in venture capital 



“Having researchers, clinicians, industry and government located under one roof creates the right conditions to accelerate innovation to commercialization to better patient care.”

John Bell, Ph.D., Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute; Professor, Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa; Founder, Turnstone Biologics

 

“Ease of access to early seed capital and corporate guidance are vital to creating an entrepreneurial environment led by innovators, risk-takers, disruptors and future-thinkers. This financial investment, coupled with the right facilities and access to talent, are the ingredients to innovation...

The AMRC and Ottawa Health Innovation Hub will significantly increase ‘deal-flow’ out of Ottawa and ultimately contribute to better healthcare outcomes in Canada.”

Jamie Stiff, Managing Partner, Genesys Capital Ventures